Zobrazeno 1 - 10
of 3 529
pro vyhledávání: '"quantiferon"'
Autor:
Uddin MKM, Islam A, Jabin MS, Alam T, Khair S, Ferdous J, Nasrin R, Rahman SMM, Pouzol S, Hoffmann J, Banu S
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 3925-3932 (2024)
Mohammad Khaja Mafij Uddin,1 Ashabul Islam,1 Maha Sultana Jabin,1 Tahmina Alam,2 Salwa Khair,1 Jannatul Ferdous,1 Rumana Nasrin,1 S M Mazidur Rahman,1 Stephane Pouzol,3 Jonathan Hoffmann,3 Sayera Banu1 1Infectious Diseases Division, Icddr,B, Dhaka, B
Externí odkaz:
https://doaj.org/article/24bf2f27f917411281d564879ffb47fb
Autor:
Shima Mahmoudi, Sadra Nourazar
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Accurate tuberculosis (TB) diagnosis remains challenging, especially in resource-limited settings. This study aims to assess the diagnostic performance of the QIAreach QuantiFERON-TB (QFT) assay, with a specific focus on comparing its diagno
Externí odkaz:
https://doaj.org/article/879f1f2d97df48a08c09ffb9b9be2c85
Publikováno v:
JAAD International, Vol 16, Iss , Pp 183-185 (2024)
Externí odkaz:
https://doaj.org/article/42348dcc69a14f599ab67c18047f8a66
Autor:
Isabel Tavitian-Exley, Win Mar Kyaw, Lim Leo Kang-Yang, Kelly Foo, Irving Charles Boudville, Jeffery Lawrence Cutter, Deborah Hee Ling Ng
Publikováno v:
International Journal of Infectious Diseases, Vol 147, Iss , Pp 107166- (2024)
Objectives: Contacts of patients with infectious tuberculosis (TB) testing positive on interferon-gamma release assay (IGRA) are followed up to exclude active disease. However, identifying factors that predispose IGRA-negative contacts to TB could im
Externí odkaz:
https://doaj.org/article/313d9e2d77e240099b7faacfcf8eaa00
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 8 (2024)
ABSTRACT Interferon-gamma (IFN-γ) release assays play a pivotal role in tuberculosis infection (TBI) diagnosis, with QuantiFERON-TB Gold Plus—an enzyme-linked immunosorbent assay (ELISA)—among the most widely utilized. Newer QuantiFERON-TB platf
Externí odkaz:
https://doaj.org/article/4be3d5bf96834358bdf0e20e54970fc1
Autor:
Francesca Mariotti, Francesco Sponchiado, Filippo Lagi, Chiara Moroni, Riccardo Paggi, Seble Tekle Kiros, Vittorio Miele, Alessandro Bartoloni, Jessica Mencarini, The COCORA Working Group
Publikováno v:
Infectious Disease Reports, Vol 15, Iss 6, Pp 758-765 (2023)
Data regarding the relationship between coronavirus disease (COVID-19) and active or latent tuberculosis (TB) are discordant. We conducted a retrospective study examining the impact of latent tuberculosis infection (LTBI) on the clinical progression
Externí odkaz:
https://doaj.org/article/09eb6a085c004ed2b74c838f70e3a9be
Autor:
Paolo Solidoro, Federico Sciarrone, Francesca Sidoti, Filippo Patrucco, Elisa Zanotto, Massimo Boffini, Rocco Francesco Rinaldo, Alessandro Bondi, Carlo Albera, Antonio Curtoni, Cristina Costa
Publikováno v:
Viruses, Vol 16, Iss 8, p 1251 (2024)
The QuantiFERON CMV (QCMV) test evaluates specific adaptive immune system activity against CMV by measuring IFN-γ released by activated CD8+ T lymphocytes. We aimed to evaluate the QCMV test as a predictive tool for CMV manifestations and acute or c
Externí odkaz:
https://doaj.org/article/52f61bbbc3a2412490c877e7265cd5b5
Autor:
Jee Whang Kim, Joshua Nazareth, Joanne Lee, Hemu Patel, Gerrit Woltmann, Raman Verma, Anne O'Garra, Pranabashis Haldar
Publikováno v:
International Journal of Infectious Diseases, Vol 141, Iss , Pp 106982- (2024)
Objectives: We investigated whether quantifying the serial QuantiFERON-TB Gold (QFT) response improves tuberculosis (TB) risk stratification in pulmonary TB (PTB) contacts. Methods: A total of 297 untreated adult household PTB contacts, QFT tested at
Externí odkaz:
https://doaj.org/article/e0614db6b4e7417fbb2f0d12ebf0b111
Autor:
Paula Rodríguez-Molino, Araceli González Sánchez, Antoni Noguera-Julián, Aleix Soler-García, Patricia Martínez Paz, Ana Méndez-Echevarría, Fernando Baquero-Artigao, Miguel González Muñoz, María Jesús Ruíz-Serrano, Manuel Monsonís, Rocío Sánchez León, Jesús Saavedra-Lozano, Begoña Santiago-García, Talía Sainz
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
We analyzed 136 children with tuberculosis disease or infection and a positive QuantiFERON-TB (QFT) assay, followed-up for a median of 21 months (0.4-11years). QFT reversed in 16.9% of cases, with significant decreases in TB1 (-1.72 vs. -0.03 IU/ml,
Externí odkaz:
https://doaj.org/article/ab6a128194ac4d37956d1559a754dde0
Autor:
Devasahayam J. Christopher, N. Priya, Deepa Shankar, Barney Isaac, Andrea DeLuca, Sonali Sarkar, Senbagavalli Prakash Babu, Prasanna Samuel, Adithya Cattamanchi, Amita Gupta, Jerrold Ellner, Sudha Srinivasan, Samyra Cox, Balamugesh Thangakunam
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 34, Iss , Pp 100404- (2024)
Background: In India, the prevalence of Latent TB infection (LTBI) is estimated to be around 40%. Various formulations of PPD(Purified protein derivative) are available, for diagnosis of LTBI, which may give variable responses. The commercially avail
Externí odkaz:
https://doaj.org/article/5e526dc9f294453294949b983ea51b74